Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (344)
|
Core Tip (384)
|
Full Article (HTML) (1488)
|
Figures (1-1) (262)
|
Full Article (PDF)-1204K (105)
|
Full Article with Cover (PDF)-11949K (95)
|
Full Article (XML)-236K (51)
|
Audio-1342K (5)
|
Peer-Review Report-230K (54)
|
Answering Reviewers-97K (53)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4047)
|
Similar Articles (75)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (367)
|
Core Tip (397)
|
Full Article (HTML) (1032)
|
Tables (1-1) (284)
|
Full Article (PDF)-358K (93)
|
Full Article with Cover (PDF)-11106K (75)
|
Full Article (XML)-54K (47)
|
Audio-1072K (7)
|
Peer-Review Report-236K (48)
|
Answering Reviewers-62K (42)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3306)
|
Similar Articles (19)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions
World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (404)
|
Core Tip (339)
|
Full Article (HTML) (3656)
|
Figures (1-2) (242)
|
Tables (1-5) (233)
|
Full Article (PDF)-1655K (167)
|
Full Article with Cover (PDF)-12399K (127)
|
Full Article (XML)-226K (48)
|
Audio-1259K (4)
|
Peer-Review Report-216K (54)
|
Answering Reviewers-145K (49)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (6027)
|
Similar Articles (61)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (425)
|
Core Tip (333)
|
Full Article (HTML) (2598)
|
Figures (1-1) (267)
|
Full Article (PDF)-601K (192)
|
Full Article with Cover (PDF)-11346K (69)
|
Full Article (XML)-89K (55)
|
Audio-384K (5)
|
Peer-Review Report-180K (44)
|
Answering Reviewers-74K (52)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (4842)
|
Similar Articles (329)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (426)
|
Core Tip (363)
|
Article Highlights (385)
|
Full Article (HTML) (1655)
|
Figures (1-4) (259)
|
Tables (1-3) (239)
|
Full Article (PDF)-1672K (90)
|
Full Article with Cover (PDF)-12418K (90)
|
Full Article (XML)-173K (45)
|
Audio-467K (6)
|
Peer-Review Report-182K (44)
|
Answering Reviewers-71K (63)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4766)
|
Similar Articles (1952)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (391)
|
Core Tip (391)
|
Article Highlights (467)
|
Full Article (HTML) (1480)
|
Figures (1-3) (267)
|
Tables (1-2) (235)
|
Full Article (PDF)-1874K (87)
|
Full Article with Cover (PDF)-12619K (85)
|
Full Article (XML)-114K (43)
|
Audio-386K (8)
|
Peer-Review Report-233K (59)
|
Answering Reviewers-161K (58)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5312)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication
World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (332)
|
Core Tip (335)
|
Article Highlights (383)
|
Full Article (HTML) (977)
|
Figures (1-4) (236)
|
Full Article (PDF)-5746K (84)
|
Full Article with Cover (PDF)-16492K (70)
|
Full Article (XML)-96K (52)
|
Audio-3997K (6)
|
Peer-Review Report-192K (47)
|
Answering Reviewers-146K (53)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3480)
|
Similar Articles (41)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (371)
|
Core Tip (355)
|
Article Highlights (393)
|
Full Article (HTML) (1753)
|
Figures (1-4) (216)
|
Tables (1-5) (236)
|
Full Article (PDF)-6006K (109)
|
Full Article with Cover (PDF)-16750K (80)
|
Full Article (XML)-200K (43)
|
Audio-376K (3)
|
Peer-Review Report-182K (48)
|
Answering Reviewers-60K (57)
|
Supplementary Material-355K (58)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5593)
|
Similar Articles (1806)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (339)
|
Core Tip (392)
|
Article Highlights (388)
|
Full Article (HTML) (1125)
|
Figures (1-4) (234)
|
Tables (1-4) (243)
|
Full Article (PDF)-5941K (82)
|
Full Article with Cover (PDF)-16687K (62)
|
Full Article (XML)-115K (44)
|
Audio-187K (9)
|
Peer-Review Report-215K (42)
|
Answering Reviewers-37K (55)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4587)
|
Similar Articles (2390)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (355)
|
Core Tip (343)
|
Full Article (HTML) (917)
|
Figures (1-1) (281)
|
Full Article (PDF)-5068K (73)
|
Full Article with Cover (PDF)-15813K (60)
|
Full Article (XML)-63K (40)
|
Audio-811K (3)
|
Peer-Review Report-266K (49)
|
Answering Reviewers-225K (45)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3566)
|
Similar Articles (4106)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (342)
|
Core Tip (342)
|
Full Article (HTML) (912)
|
Full Article (PDF)-325K (79)
|
Full Article with Cover (PDF)-11079K (63)
|
Full Article (XML)-24K (54)
|
Audio-243K (1)
|
Peer-Review Report-215K (38)
|
Answering Reviewers-19K (38)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2543)
|
Similar Articles (389)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open